How microRNA affects bone health and glucocorticoid signaling
MicroRNA regulation of osteoblast physiology and glucocorticoid signaling
This study is looking at how a tiny molecule called microRNA-433 affects bone health and how it interacts with hormones that can weaken bones, with the goal of finding new ways to help people whose bones are at risk due to these hormones.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Connecticut Sch of Med/dnt NIH-funded |
| Lab location | 1 site (Farmington, United States) |
| Project ID | NIH-10974479 on NIH RePORTER |
What this research studies
This research investigates the role of microRNA-433 in regulating bone health and the effects of glucocorticoids, which are hormones that can negatively impact bone density when present in excess. The study involves both laboratory experiments and the use of genetically modified mice to explore how inhibiting microRNA-433 can enhance the responsiveness of bone-forming cells to glucocorticoids and promote bone formation. By understanding these mechanisms, the research aims to identify potential therapeutic targets for improving bone health in patients affected by glucocorticoid excess.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with conditions that lead to glucocorticoid excess, such as Cushing’s disease, or those undergoing glucocorticoid treatment.
Not a fit: Patients with bone health issues unrelated to glucocorticoid signaling may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve bone health and prevent bone loss in patients with conditions like Cushing’s disease or those receiving glucocorticoid therapy.
How similar studies have performed: Other research has shown promising results in targeting microRNAs for therapeutic purposes, indicating that this approach may hold significant potential.
Where this research is happening
Farmington, United States
- University of Connecticut Sch of Med/dnt — Farmington, United States (Active)
Researchers
- Principal investigator: Delany, Anne M — University of Connecticut Sch of Med/dnt
- Study coordinator: Delany, Anne M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.